Upstart Holdings is slated to report its second-quarter (Q2) earnings results on Tuesday after-hours.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Advanced Energy Industries Inc (AEIS) posts record Q2 2026 results with revenue up 30% year-over-year, raises full-year outlook on strong demand and new product traction.
ON Semiconductor Corp (ON) reports strong Q2 2026 results with record free cash flow and a bullish outlook on AI data center growth, despite near-term supply constraints.
BWXT posts 18% revenue growth, raises full-year guidance, and sharpens focus on nuclear core markets with $800 million medical business sale.
Adeia Inc (ADEA) raises long-term revenue target to $600M as non-Pay-TV recurring revenue nearly doubles Pay-TV, driven by hybrid bonding adoption and strategic diversification.
Palantir Technologies Inc (PLTR) delivers its strongest quarter ever with US commercial revenue surging 149% and a Rule of 40 score of 155%.
Backblaze Inc (BLZE) beats Q2 revenue guidance by $2.5M, signs largest contract in company history, and raises full-year 2026 outlook amid accelerating B2 Cloud growth.
I’ve just returned to the office after an approximately 1,500-mile run across the American West on one of my favorite motorcycles – and I LOVE what I see. “Buy the best, ignore the rest” is as true today as it was years ago, notes Keith Fitz-Gerald, editor of 5 With Fitz.
Lamb Weston trades at $51.95 per share and has stayed right on track with the overall market, gaining 12.2% over the last six months. At the same time, the S&P 500 has returned 8.3%.
Goldman Sachs trades at $1,016 and has moved in lockstep with the market. Its shares have returned 8.2% over the last six months while the S&P 500 has gained 8.3%.
Record $36B quarterly fundraising drives 17% AUM growth and 20% fee-related earnings increase.
Record $12.1B backlog and 50% HVAC bookings growth signal strong data center demand ahead.
Grab (NASDAQ:GRAB) reported record second-quarter results, with adjusted EBITDA rising 54% year over year to $168 million as the Southeast Asian technology company continued to expand margins, grow its user base and integrate newly acquired financial-services businesses. Chief Executive Officer Ant
Revenue declined to $152M amid cautious customer demand and rising component costs.
Record indium phosphide revenue surges 164% as AI data center demand accelerates.
Revenue surged 61% year over year with profitability metrics more than doubling.
Refining margins expected to hold through 2027 as global product restocking continues.
EPS grew 2.8% as Marlboro pricing offset volume declines and oral tobacco expanded.
Growth portfolio now drives 60% of revenue as Eliquis surges 21%.
Base network hits $32 trillion volume as subscription revenue gains traction.
Data center pipeline expansion and $70 billion investment plan take center stage.
R2 ramp accelerates as software revenue surges 37% on Volkswagen partnership gains.
Enterprise data revenue surged 45% sequentially as AI and server demand accelerated.
Snap (NYSE:SNAP) reported second-quarter revenue growth of 19% as the company cited improving advertising performance, rapid expansion in subscription-related revenue and increased cash generation. The company also said it is shifting its primary financial objective toward free cash flow per share w
Inspire Medical Systems (NYSE:INSP) reported second-quarter revenue of $200.6 million, down 7.6% from a year earlier, as coding and reimbursement disruptions continued to affect procedure volumes. The company said results exceeded its internal expectations for profitability and cash flow, prompting
Marketing technology company Zeta Global (NYSE:ZETA) will be reporting earnings this Tuesday after market close. Here’s what you need to know.
Ameresco (NYSE:AMRC) reported second-quarter 2026 revenue of $515 million, up 9% from a year earlier, while highlighting a record $1.8 billion in new project awards led by data center-related power infrastructure projects. Chairman and Chief Executive Officer George Sakellaris described the quarter
BWX Technologies (NYSE:BWXT) reported second-quarter 2026 revenue growth of 18% and raised its full-year financial outlook, citing continued demand across nuclear national security and commercial power markets. Second-quarter revenue reached $902 million, including 9% organic growth, while adjusted
Vertex Pharmaceuticals (NASDAQ:VRTX) reported second-quarter 2026 revenue growth of 12% year over year to $3.3 billion, driven by continued growth in its cystic fibrosis franchise and rising contributions from newer products CASGEVY and JOURNAVX. Chief Executive Officer and President Reshma Kewalra